- Home
- CLGN vs PIII Comparison
CLGN vs PIII Comparison
Compare CLGN & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- PIII
- Stock Information
- Founded
- CLGN 2004
- PIII 2015
- Country
- CLGN Israel
- PIII United States
- Employees
- CLGN N/A
- PIII N/A
- Industry
- CLGN Industrial Specialties
- PIII Medical/Nursing Services
- Sector
- CLGN Health Care
- PIII Health Care
- Exchange
- CLGN Nasdaq
- PIII Nasdaq
- Market Cap
- CLGN 20.4M
- PIII 21.4M
- IPO Year
- CLGN N/A
- PIII N/A
- Fundamental
- Price
- CLGN $1.48
- PIII $6.25
- Analyst Decision
- CLGN Strong Buy
- PIII Buy
- Analyst Count
- CLGN 2
- PIII 2
- Target Price
- CLGN $11.50
- PIII $16.25
- AVG Volume (30 Days)
- CLGN 272.0K
- PIII 4.5K
- Earning Date
- CLGN 08-19-2025
- PIII 08-06-2025
- Dividend Yield
- CLGN N/A
- PIII N/A
- EPS Growth
- CLGN N/A
- PIII N/A
- EPS
- CLGN N/A
- PIII N/A
- Revenue
- CLGN $2,472,000.00
- PIII $1,485,192,000.00
- Revenue This Year
- CLGN $2,177.67
- PIII N/A
- Revenue Next Year
- CLGN $56.52
- PIII $6.01
- P/E Ratio
- CLGN N/A
- PIII N/A
- Revenue Growth
- CLGN N/A
- PIII 9.79
- 52 Week Low
- CLGN $1.40
- PIII $6.20
- 52 Week High
- CLGN $5.48
- PIII $32.54
- Technical
- Relative Strength Index (RSI)
- CLGN 41.46
- PIII 30.83
- Support Level
- CLGN $1.40
- PIII $6.20
- Resistance Level
- CLGN $1.83
- PIII $6.74
- Average True Range (ATR)
- CLGN 0.26
- PIII 0.25
- MACD
- CLGN -0.08
- PIII 0.01
- Stochastic Oscillator
- CLGN 4.11
- PIII 0.00
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.